Variant report

Variant	nsv597325
Chromosome Location	chr5:17352326-17356166
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:89)
CpG islands
(count:244)
Chromatin interactive
region (count:2)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:89 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr5:17354193-17354509	GM12878	blood:	n/a	n/a
2	BATF	chr5:17353871-17354044	GM12878	blood:	n/a	n/a
3	BATF	chr5:17354195-17354502	GM12878	blood:	n/a	n/a
4	BCL11A	chr5:17352535-17352691	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr5:17356136-17356434	IMR90	lung:	n/a	n/a
6	CEBPB	chr5:17353388-17353588	A549	lung:	n/a	n/a
7	EBF1	chr5:17355821-17355957	GM12878	blood:	n/a	chr5:17355858-17355869
8	EBF1	chr5:17354257-17354470	GM12878	blood:	n/a	n/a
9	EBF1	chr5:17354246-17354448	GM12878	blood:	n/a	n/a
10	EP300	chr5:17352504-17352852	H1-hESC	embryonic stem cell:	n/a	n/a
11	FOS	chr5:17356011-17356504	MCF10A-Er-Src	breast:	n/a	chr5:17356250-17356261 chr5:17356172-17356183
12	FOS	chr5:17356020-17356443	MCF10A-Er-Src	breast:	n/a	chr5:17356250-17356261 chr5:17356172-17356183
13	FOS	chr5:17356035-17356437	MCF10A-Er-Src	breast:	n/a	chr5:17356250-17356261 chr5:17356172-17356183
14	FOS	chr5:17356078-17356392	HUVEC	blood vessel:	n/a	chr5:17356250-17356261 chr5:17356172-17356183
15	FOS	chr5:17356012-17356441	MCF10A-Er-Src	breast:	n/a	chr5:17356250-17356261 chr5:17356172-17356183
16	GATA2	chr5:17353802-17354221	K562	blood:	n/a	n/a
17	HEY1	chr5:17353803-17353988	HepG2	liver:	n/a	n/a
18	HEY1	chr5:17354496-17354799	HepG2	liver:	n/a	n/a
19	HEY1	chr5:17354309-17354764	K562	blood:	n/a	n/a
20	HEY1	chr5:17354053-17354238	HepG2	liver:	n/a	n/a
21	HEY1	chr5:17353758-17354777	K562	blood:	n/a	n/a
22	HEY1	chr5:17353756-17354227	HepG2	liver:	n/a	n/a
23	HEY1	chr5:17354562-17354746	HepG2	liver:	n/a	n/a
24	IRF4	chr5:17353792-17354328	GM12878	blood:	n/a	n/a
25	IRF4	chr5:17353911-17354417	GM12878	blood:	n/a	n/a
26	MYC	chr5:17356129-17356390	MCF10A-Er-Src	breast:	n/a	n/a
27	MYC	chr5:17354494-17354599	MCF-7	breast:	n/a	n/a
28	PAX5	chr5:17353778-17354526	GM12878	blood:	n/a	n/a
29	PAX5	chr5:17354041-17354271	GM12878	blood:	n/a	n/a
30	POLR2A	chr5:17354625-17354696	MCF-7	breast:	n/a	n/a
31	POLR2A	chr5:17354515-17354735	MCF-7	breast:	n/a	n/a
32	POLR2A	chr5:17354634-17354748	H1-hESC	embryonic stem cell:	n/a	n/a
33	POLR2A	chr5:17354050-17354519	Hela-S3	cervix:	n/a	n/a
34	POLR2A	chr5:17353811-17354807	GM12891	blood:	n/a	n/a
35	POLR2A	chr5:17354266-17354740	GM12878	blood:	n/a	n/a
36	POLR2A	chr5:17354581-17354583	MCF-7	breast:	n/a	n/a
37	POLR2A	chr5:17354345-17354731	A549	lung:	n/a	n/a
38	POLR2A	chr5:17353763-17354905	Hela-S3	cervix:	n/a	n/a
39	POLR2A	chr5:17353761-17354800	GM12878	blood:	n/a	n/a
40	POLR2A	chr5:17354202-17354770	GM12891	blood:	n/a	n/a
41	POLR2A	chr5:17354586-17354587	MCF-7	breast:	n/a	n/a
42	POLR2A	chr5:17354519-17354560	MCF-7	breast:	n/a	n/a
43	POLR2A	chr5:17354371-17354651	A549	lung:	n/a	n/a
44	POLR2A	chr5:17354533-17354753	Hela-S3	cervix:	n/a	n/a
45	POLR2A	chr5:17353814-17354425	H1-hESC	embryonic stem cell:	n/a	n/a
46	POLR2A	chr5:17353767-17354792	GM12891	blood:	n/a	n/a
47	POLR2A	chr5:17354589-17354605	MCF-7	breast:	n/a	n/a
48	POLR2A	chr5:17353940-17354750	GM12892	blood:	n/a	n/a
49	POLR2A	chr5:17354588-17354790	GM12892	blood:	n/a	n/a
50	POLR2A	chr5:17354463-17354728	HepG2	liver:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:17354521-17354571	ECC-1	luminal epithelium:	n/a
2	chr5:17354521-17354571	HCT-116	colon:	n/a
3	chr5:17354504-17354554	NHBE	bronchial:	n/a
4	chr5:17354504-17354554	GM19239	blood:	n/a
5	chr5:17352463-17352513	GM12892	blood:	n/a
6	chr5:17354674-17354724	HepG2	liver:	n/a
7	chr5:17354504-17354554	BJ	skin:	n/a
8	chr5:17354674-17354724	NB4	blood:	n/a
9	chr5:17354674-17354724	BJ	skin:	n/a
10	chr5:17354521-17354571	HIPEpiC	eye:	n/a
11	chr5:17354504-17354554	PrEC	prostate:	n/a
12	chr5:17354521-17354571	HCF	heart:	n/a
13	chr5:17354674-17354724	A549	lung:	n/a
14	chr5:17352463-17352513	K562	blood:	n/a
15	chr5:17354674-17354724	U87	brain:	n/a
16	chr5:17354504-17354554	SK-N-MC	brain:	n/a
17	chr5:17354504-17354554	Jurkat	blood:	n/a
18	chr5:17354521-17354571	RPTEC	kidney:	n/a
19	chr5:17352463-17352513	IMR90	lung:	fetal
20	chr5:17354674-17354724	GM19239	blood:	n/a
21	chr5:17354674-17354724	NT2-D1	testis:	n/a
22	chr5:17354504-17354554	AG09319	gingival:	n/a
23	chr5:17352463-17352513	HAEpiC	amniotic membrane:	n/a
24	chr5:17354521-17354571	SK-N-MC	brain:	n/a
25	chr5:17354521-17354571	LNCaP	prostate:	n/a
26	chr5:17354521-17354571	HRPEpiC	eye:	n/a
27	chr5:17352463-17352513	AG09319	gingival:	n/a
28	chr5:17354504-17354554	NT2-D1	testis:	n/a
29	chr5:17354674-17354724	HPAEpiC	pulmonary alveolar:	n/a
30	chr5:17354674-17354724	AG10803	skin:	n/a
31	chr5:17352463-17352513	RPTEC	kidney:	n/a
32	chr5:17354521-17354571	BJ	skin:	n/a
33	chr5:17352463-17352513	U87	brain:	n/a
34	chr5:17352463-17352513	SK-N-MC	brain:	n/a
35	chr5:17354504-17354554	MCF-7	breast:	n/a
36	chr5:17354504-17354554	NB4	blood:	n/a
37	chr5:17354521-17354571	GM19239	blood:	n/a
38	chr5:17352463-17352513	AG10803	skin:	n/a
39	chr5:17352463-17352513	PFSK-1	brain:	n/a
40	chr5:17354521-17354571	IMR90	lung:	fetal
41	chr5:17354504-17354554	Hela-S3	cervix:	n/a
42	chr5:17354521-17354571	SKMC	muscle:	n/a
43	chr5:17354674-17354724	Hepatocyte	liver:	n/a
44	chr5:17354521-17354571	HRE	kidney:	n/a
45	chr5:17354504-17354554	HCT-116	colon:	n/a
46	chr5:17354674-17354724	HCM	heart:	n/a
47	chr5:17354521-17354571	NH-A	brain:	n/a
48	chr5:17354504-17354554	SAEC	small airway:	n/a
49	chr5:17354674-17354724	Jurkat	blood:	n/a
50	chr5:17354674-17354724	NHBE	bronchial:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:61734609..61735212-chr5:17354143..17355140,3	Hela-S3	cervix:
2	chr5:17348620..17350126-chr5:17350951..17353449,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BASP1-1	chr5:17354019-17354119	ENSG00000248223
2	lnc-BASP1-1	chr5:17354243-17355008	ENSG00000248223

No data

Variant related genes	Relation type
FTH1P10	TF binding region
ENSG00000248223	TF binding region
FTH1P10	CpG island
ENSG00000248223	CpG island
ENSG00000167996	chromatin interactions

Extended variants
information (count: 189 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:189 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs562036801	chr5:17352331-17352332	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs527785787	chr5:17352364-17352365	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs533603338	chr5:17352374-17352375	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs547631709	chr5:17352397-17352398	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs2173968	chr5:17352407-17352408	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs533597838	chr5:17352442-17352443	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs530916843	chr5:17352463-17352464	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
8	rs73054816	chr5:17352464-17352465	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs567021535	chr5:17352484-17352485	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs80053876	chr5:17352487-17352488	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs181732954	chr5:17352507-17352508	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs57275523	chr5:17352599-17352600	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs533903175	chr5:17352609-17352610	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs59809655	chr5:17352632-17352633	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs553656776	chr5:17352711-17352712	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs576606584	chr5:17352767-17352768	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs2650940	chr5:17352798-17352799	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs185757098	chr5:17352805-17352806	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs146539997	chr5:17352827-17352828	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs386685930	chr5:17352859-17352860	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs2650939	chr5:17352860-17352861	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs527747766	chr5:17352884-17352885	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs541495134	chr5:17352922-17352923	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs564459625	chr5:17352944-17352945	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs538924756	chr5:17352950-17352951	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs533558699	chr5:17352952-17352953	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs557639773	chr5:17352956-17352957	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs139217563	chr5:17352960-17352961	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs570317053	chr5:17352964-17352965	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs549127187	chr5:17352972-17352973	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs112402907	chr5:17352985-17352986	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs2652641	chr5:17352988-17352989	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs533581405	chr5:17353008-17353009	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs115853447	chr5:17353037-17353038	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs570251602	chr5:17353058-17353059	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs139419124	chr5:17353068-17353069	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs201891123	chr5:17353070-17353071	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs373930144	chr5:17353071-17353072	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs200739605	chr5:17353072-17353073	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs150794068	chr5:17353086-17353087	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs146822842	chr5:17353087-17353088	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs539243130	chr5:17353110-17353111	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs2650938	chr5:17353125-17353126	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs190960392	chr5:17353144-17353145	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs58489807	chr5:17353147-17353148	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs575681474	chr5:17353199-17353200	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs2652640	chr5:17353212-17353213	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs541109511	chr5:17353245-17353246	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs563230911	chr5:17353265-17353266	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs149074046	chr5:17353274-17353275	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Multiple myeloma	17550852	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Esophageal adenocarcinoma	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	21364760	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Myoepithelioma	18604193	CNVD
Lung cancer	16740712	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Melanoma	22183965	CNVD
Renal cell carcinoma	18194544	CNVD
Prostate cancer	21965145	CNVD
Ovarian cancer	20844748	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD

Chromatin state (count:28 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:17344600-17358400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
2	chr5:17351000-17353000	Enhancers	iPS-18 Cell Line	embryonic stem cell
3	chr5:17351200-17353000	Enhancers	iPS-20b Cell Line	embryonic stem cell
4	chr5:17351200-17353000	Enhancers	Fetal Brain Male	brain
5	chr5:17351400-17352400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
6	chr5:17351400-17354400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr5:17352000-17352400	Enhancers	Fetal Brain Female	brain
8	chr5:17352000-17352600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
9	chr5:17352000-17352800	Enhancers	H9 Cell Line	embryonic stem cell
10	chr5:17352000-17353000	Enhancers	H1 Cell Line	embryonic stem cell
11	chr5:17352400-17352800	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr5:17352400-17353000	Enhancers	HUES48 Cell Line	embryonic stem cell
13	chr5:17352600-17353000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
14	chr5:17352800-17355800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr5:17353000-17353400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr5:17354400-17354800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr5:17354800-17366000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr5:17355600-17356000	Enhancers	Primary B cells from peripheral blood	blood
19	chr5:17355600-17356400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr5:17355800-17356000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
21	chr5:17355800-17356000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr5:17355800-17356000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr5:17355800-17356600	Enhancers	Muscle Satellite Cultured Cells	--
24	chr5:17355800-17356600	Enhancers	NHDF-Ad	bronchial
25	chr5:17356000-17356200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr5:17356000-17356400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr5:17356000-17356800	ZNF genes & repeats	Primary B cells from peripheral blood	blood
28	chr5:17356000-17359400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links